Coverage
-
May 04, 2018
Kessler Topaz Meltzer & Check LLP and its investor client on Friday secured the roles of lead counsel and plaintiff in a proposed securities class action against Tesaro Inc. blaming the pharmaceutical company for stock losses after regulators issued a national safety alert on its antiemetic cancer drug.
1 other articles on this case.
View all »